equityflowunderstand the flow and follow it

EquityFlow › Companies › MLA Diagnostics

MLA Diagnostics

Healthtech · NL

DNA methylation-based molecular prognostic test for early-stage melanoma.

In the network

Shares the most investors with (number = shared investors):

Funding history

Date	Round	Amount
Dec 2023	Funding round Dutch MLA Diagnostics secured an undisclosed strategic seven-figure investment from NLC Health Ventures, LIOF and Brightlands Life Sciences Ventures for melanoma diagnostics clinical trials.	—

Investors

Tap an investor to see what else they have backed.

Brightlands Life Sciences Ventures LIOF NLC Health Ventures

Other companies in Healthtech

OurMind TurnUp Nanordica Medical Uncovr 01Health Rem3dy Health Joyvié Health Semble Triomics Musely VITL Ema Health

Other companies in NL

OurMind New Dawn Bio Eddy Grid Invisix Seenons Surebird Balthazar Groove Quantum Labfresh Arceon Tebi Aquablu

Other companies at Unknown stage

&Charge /dev/agents 123-Transporter 123fahrschule 13Hz 1Global 1Komma5°1MT Nation 1Password 20Face 21.co 2NA FISH

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.